Net Cash Provided by (Used in) Operating Activities |
-194 |
USD |
|
Q1 2023 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-9K |
USD |
|
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
8B |
shares |
|
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
3.31B |
shares |
|
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-8.97K |
USD |
-4526% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
8.97K |
USD |
+258% |
Q4 2023 |
Q2 2024 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Authorized |
2B |
shares |
|
Q2 2024 |
Q2 2024 |
Additional Paid in Capital |
904K |
USD |
|
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2024 |
Q2 2024 |